Systematic Financial Management’s Organon & Co OGN Stock Holding History

Systematic Financial Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-730	Closed	-$4.37K	–	254
2026 Q1	$4.37K	Hold	730	–	–	﹤0.01%	245
2025 Q4	$5.23K	Hold	730	–	–	﹤0.01%	250
2025 Q3	$7.8K	Hold	730	–	–	﹤0.01%	244
2025 Q2	$7.07K	Hold	730	–	–	﹤0.01%	242
2025 Q1	$10.9K	Hold	730	–	–	﹤0.01%	241
2024 Q4	$10.9K	Sell	730 -37,210	-98%	-$606K	﹤0.01%	246
2024 Q3	$726K	Buy	37,940 +37,210	+5,097%	+$771K	0.02%	245
2024 Q2	$15.1K	Hold	730	–	–	﹤0.01%	245
2024 Q1	$13.7K	Hold	730	–	–	﹤0.01%	247
2023 Q4	$10.5K	Hold	730	–	–	﹤0.01%	234
2023 Q3	$12.7K	Hold	730	–	–	﹤0.01%	232
2023 Q2	$15.2K	Hold	730	–	–	﹤0.01%	224
2023 Q1	$17.2K	Hold	730	–	–	﹤0.01%	293
2022 Q4	$20.4K	Hold	730	–	–	﹤0.01%	227
2022 Q3	$17K	Hold	730	–	–	﹤0.01%	226
2022 Q2	$25K	Hold	730	–	–	﹤0.01%	227
2022 Q1	$25K	Hold	730	–	–	﹤0.01%	226
2021 Q4	$22K	Hold	730	–	–	﹤0.01%	230
2021 Q3	$24K	Hold	730	–	–	﹤0.01%	228
2021 Q2	$22K	Buy	+730	New	+$24K	﹤0.01%	231

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Systematic Financial Management's OGN Position: Q2 2026 in Review

Systematic Financial Management sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 730 shares — an estimated $4.37K sold.

Systematic Financial Management first reported a position in OGN in Q2 2021 and held it in 20 quarters. The position peaked at $726K in Q3 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Systematic Financial Management reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Systematic Financial Management sold 730 Organon & Co shares in Q2 2026, an estimated $4.37K.
Systematic Financial Management first reported a position in Organon & Co in Q2 2021 and held it in 20 quarters.
Systematic Financial Management's Organon & Co position peaked at $726K in Q3 2024.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Systematic Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.